EVOLENT HEALTH INC - NOTE 1.500%10/1

CUSIP: 30050BAD3

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Debt / NOTE 1.500%10/1
Market price (% of par)
96.88%
Total 13F principal
$171,719,000
Principal change
-$11,243,000
Total reported market value
$167,318,058
Number of holders
9
Value change
-$12,154,486
Number of buys
3
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 30050BAD3?
CUSIP 30050BAD3 identifies 30050BAD3 - EVOLENT HEALTH INC - NOTE 1.500%10/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EVOLENT HEALTH INC - NOTE 1.500%10/1 as of Q4 2024

As of 31 Dec 2024, EVOLENT HEALTH INC - NOTE 1.500%10/1 was held by 9 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $171,719,000 in principal (par value) of the bond. The largest 9 bondholders included TENOR CAPITAL MANAGEMENT Co., L.P., DeepCurrents Investment Group LLC, LAZARD ASSET MANAGEMENT LLC, Sonora Investment Management Group, LLC, JPMORGAN CHASE & CO, BLAIR WILLIAM & CO/IL, PALISADE CAPITAL MANAGEMENT, LP, BANK OF AMERICA CORP /DE/, and MORGAN STANLEY. This page lists 9 institutional bondholders reporting positions for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.